Chemical Biology Consortium Sweden (CBCS) was established in 2010 through the joint efforts of academic and industrial researchers within small-molecule discovery, funding provided by the Swedish Research Council, and the host universities Karolinska Institutet, Umeå University and Uppsala University. Through a VINNOVA-funded planning phase in 2009, it was clearly identified that academic basic research in Sweden would substantially benefit from access to a nationally encompassing, independent chemical biology infrastructure.
The most important scientific value of CBCS will be enabling of high-impact research within the field of chemical biology in Sweden by providing the combination of a state-of-the-art infrastructure and industrial know-how for the generation of high-quality chemical tools. CBCS as a platform is available on a national level to all Swedish universities. In the long term, findings from the chemical biology community in Sweden has the potential to result in groundbreaking biological discoveries, validation of new drug targets and novel concepts for the development of useful therapeutics and diagnostics.